PhD in Food Technology/ Pharmaceutics/ Pharmacognosy / Pharmacology Or M. Tech Food Technology/ M. Pharm. Pharmaceutics / Pharmacognosy / Pharmacology with minimum of 60% marks or 6.5/10 CGPA. Jamia Hamdard, New Delhi.
M.Sc. in Life Science / Taxonomy / Agriculture / Pharmacology / Chemistry / Bioinformatics at CSIR – North East Institute of Science & Technology, Jorhat
PhD. in Chemistry / Biological / Pharmaceutical Sciences. Repurposing and Validating the FDA-approved UDP-Glucose Ceramide Glucosyltransferase (UGCG) Inhibitor Eliglustat as a Potential Intervention for Breast and Oral Cancer Immunotherapy.
The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).
University degree in medicine, science, or equivalent. Working independently and actively to coordinate all activities for setting up and monitoring a study, completing accurate study status reports and maintaining study documentation
M.Pharm as Executive Pharmacokinetics. Literature search and study designing of Bioavailability and Bioequivalence studies of oral & non-oral products towards different regulatory submission. Sun Pharma
A minimum of a BA or BS degree in Pharmacy, Nursing, Life Sciences, or related scientific field (or equivalent experience) is required. Johnson & Johnson
MSc. in Life Sciences or related natural science disciplines from recognized Universities or equivalent, with at least 60% marks. Regional Centre for Biotechnology
The incumbent will support the implementation of internal standards, provide study-level CDISC guidance, conduct quality reviews of deliverables from CRO partners, and ensure clinical data packages meet inspection-readiness criteria for global health authorities.
Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies of the Country. The Company was a pioneer in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).
Proven track record of leading practice change and pioneering new technologies or ways of working, with measurable impact in biomedical, clinical or drug development settings.
Zydus Lifesciences launched Tishtha in January 2026, becoming the first company to introduce a nivolumab biosimilar in India. Dr. Reddy’s Laboratories entered the market with NIVORZ in September 2026, adding another Indian-developed option for patients requiring cancer immunotherapy.
The U.S. Food and Drug Administration (FDA) has approved HOVILPRI (pritelivir) tablets for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) infection in immunocompromised adults whose infections have not responded to standard antiviral treatments.